Patents for C12R 1 - Micro-organisms (92,025) |
---|
06/05/2001 | US6242250 Determined DNA sequences derived from a papillomavirus genome, their uses for in vitro diagnostic purposes and the production of antigenic compositions |
06/05/2001 | US6242241 Nucleotide and amino acid sequences; transgenic plants; transformed host cells |
06/05/2001 | US6242237 Dna construct encoding a galactanase having ph optimum above 5.9 from myceliophthora thermophila or humicola insolens; animal feed additive; wine and juice processing |
06/05/2001 | US6242234 Mutants of formate dehydrogenase from Candida boidinii, new gene sequences encoding these and use of the new formate dehydrogenases |
06/05/2001 | US6242233 Aldehyde dehydrogenase |
06/05/2001 | US6242226 Products containing a dextran composition obtained from culturing Leuconostoc mesenteroidesssp. cremoris |
06/05/2001 | US6242220 Method for purifying covalently closed circular DNA |
06/05/2001 | US6242201 Detection of protein that preferentially binds to proliferating cells; for the treatment of psoriasis, cancer and cell proliferative defect |
06/05/2001 | US6242199 Detecting ligand associated with hormone release; transform cells with vector, transform cells with vector coding light protein, incubate cells with binding protein, detect binding activity |
06/05/2001 | CA2168429C Expression of fusion polypeptides transported out of cytoplasm without leader sequences |
06/05/2001 | CA2155335C Improved method for the refolding of proteins |
06/05/2001 | CA2155185C Totally synthetic affinity reagents |
06/05/2001 | CA2124937C T-pa substitution variants with improved fibrin-specificity |
06/05/2001 | CA2112408C Monoclonal antibody to lymphocyte-associated cell surface protein |
06/05/2001 | CA2005502C Somatotropin analogs |
06/05/2001 | CA1341242C Dna sequence, vectors, recombinant viruses, and process involving recombinant cowpox viruses capable of multiplying in cho cells |
06/05/2001 | CA1341241C Expression of a tumor-specific antigen through a recombinant virus vector, and its use for prevention or cure of the corresponding tumor |
06/02/2001 | CA2325594A1 Novel nucleotide sequences coding for the gpm gene |
06/02/2001 | CA2325227A1 New nucleotide sequences coding for the glk-gene |
05/31/2001 | WO2001038549A1 Compositions and methods utilizing sequences for controlling nucleic acid expression in yeast |
05/31/2001 | WO2001038541A1 Moss genes from physcomitrella patents encoding proteins involved in the synthesis of polyunsaturated fatty acids and lipids |
05/31/2001 | WO2001038538A1 Polymerase compositions and methods of use thereof |
05/31/2001 | WO2001038532A2 Reagents and methods for identifying and modulating expression of genes regulated by cdk inhibitors |
05/31/2001 | WO2001038503A2 Novel human protein kinases and protein kinase-like enzymes |
05/31/2001 | WO2001038484A2 Moss genes from physcomitrella patens coding proteins involved in the synthesis of polyunsaturated fatty acids and lipids |
05/31/2001 | WO2001038362A2 Production of vaccines |
05/31/2001 | WO2001038358A2 Hbv/hcv virus-like particle |
05/31/2001 | WO2001037865A1 Compositions and methods for treatment of allergic disorders |
05/31/2001 | WO2001016327A3 Method for producing a channel-forming protein |
05/31/2001 | WO2001007626A3 Methods for producing l-amino acids by increasing cellular nadph |
05/31/2001 | WO2001002571A3 An interleukin-1 receptor antagonist and uses thereof |
05/31/2001 | WO2000071748A3 Ers-genes, method of screening for chemical compounds capable of inducing ers in plants |
05/31/2001 | WO2000066708A3 Asthma associated factors as targets for treating atopic allergies including asthma and related disorders |
05/31/2001 | WO2000050072A3 Method for the purification, recovery, and sporulation of cysts and oocysts |
05/31/2001 | WO2000032772A3 Erythropoietic compounds |
05/31/2001 | WO2000017327A3 Terpene synthases |
05/31/2001 | WO2000012735A3 Transgene assay using stable agrobacterium rhizogenes transformation |
05/31/2001 | US20010002489 Methods for increasing stearate content in soybean oil |
05/31/2001 | DE19956686A1 Neue für die Gene sucC und sucD codierende Nukleotidsequenzen New codes for genes sucC and sucD nucleotide sequences |
05/31/2001 | DE19956131A1 Neue für das pfk-Gen codierende Nukleotidsequenzen New coding for the pfk gene nucleotide sequences |
05/31/2001 | CA2394803A1 Novel human protein kinases and protein kinase-like enzymes |
05/31/2001 | CA2392527A1 Hbv/hcv virus-like particle |
05/31/2001 | CA2392495A1 Reagents and methods for identifying and modulating expression of genes regulated by cdk inhibitors |
05/31/2001 | CA2392475A1 Moss genes from physcomitrella patens coding proteins involved in the synthesis of polyunsaturated fatty acids and lipids |
05/31/2001 | CA2391499A1 Compositions and methods for treatment of allergic disorders |
05/30/2001 | EP1103623A1 Human mucin core protein: nucleic acid probes, peptide fragments and antibodies thereto, and uses thereof in diagnostic and therapeutic methods |
05/30/2001 | EP1103620A1 Process for preparing (s)-3-halogeno-1,2-propanediol by Pseudomonas |
05/30/2001 | EP1103616A2 Synthetic plant genes and method for preparation |
05/30/2001 | EP1103613A1 Nucleotide sequences coding for the pfk gene |
05/30/2001 | EP1103611A1 Nucleotide sequences coding for the genes sucC and sucD |
05/30/2001 | EP1103610A1 Production of vaccines from immortalised mammalian cell lines |
05/30/2001 | EP1102858A2 Cell lines for the propagation of mutated herpes viruses |
05/30/2001 | EP1102849A2 A plant disease resistance signalling gene: materials and methods relating thereto |
05/30/2001 | EP1102848A2 Molecules designated ldcam |
05/30/2001 | EP1102846A1 Pancreatic and ovarian polypeptide, zsig58 |
05/30/2001 | EP1102790A2 Immunological herpes simplex virus antigens and methods for use thereof |
05/30/2001 | EP1102595A2 Methods for increasing the solubility of nutritional materials using probiotic lactic acid-producing bacteria |
05/30/2001 | EP1102528A1 Translation control elements for high-level protein expression in the plastids of higher plants and methods of use thereof |
05/30/2001 | EP0662093B1 Hiv immunotherapeutics |
05/30/2001 | CN1297485A i (streptomyces avermitilis) gene directing ratio of B2:B1 avermectins |
05/30/2001 | CN1297452A Modified factor VIII |
05/30/2001 | CN1297055A New nucleotide sequence for coding pfk gene |
05/30/2001 | CN1297054A New nucleotide sequence for coding pfkA gene |
05/30/2001 | CN1296953A Mycoplasma hyopnaumoniae (mhp) 3 gene nuclein and protein, and use thereof |
05/30/2001 | CN1066488C Bioprocess for preparing 7-ADCA |
05/30/2001 | CN1066486C Riboflavinover producing strains of bacteria |
05/30/2001 | CN1066345C Growth hormone releasing factor analogs |
05/29/2001 | US6239330 Fumonisin detoxification compositions and methods |
05/29/2001 | US6239329 Shoot meristem specific promoter sequences |
05/29/2001 | US6239316 Optically active secondary alcohol and process for the production thereof |
05/29/2001 | US6239267 Nucleotide sequence of ion channel protein associated with capsaicin; diagnosis and treatment of nervous system disorders, incontinence, stroke; antiischemic agents; antiarthritic/antiinflammatory agents; analgesics |
05/29/2001 | US6239264 Nucleotide sequences; cloning vectors; transformed host cells; primers for detection |
05/29/2001 | US6239106 Family of protease inhibitors, and other biologic active substances |
05/29/2001 | US6238914 Nucleic acid |
05/29/2001 | US6238898 Hydroperoxide lyases |
05/29/2001 | US6238895 Culture product; from fumaric acid |
05/29/2001 | US6238894 Culture product of helicobacter; catalyst |
05/29/2001 | US6238892 Preferential immunoglobulin for the diagnosis and treatment of alzheimer's disease and nervous system disorders |
05/29/2001 | US6238882 Nucleotide sequence from streptococcus; diagnosis; drug screening for new bactericides; primers; probes; antibodies; vaccines |
05/29/2001 | US6238875 Immunoassay diagnosis of chronic lymphocytic leukemia in humans by detecting and quantitating gene expression of effector cell protease receptors on cd5 positive sample cells |
05/29/2001 | US6238861 Neurofibromatosis gene |
05/29/2001 | US6238859 Virus protein antigens of the JC virus |
05/29/2001 | CA2326854A1 Process for preparing (s)-3-halogeno-1,2-propanediol by microorganism |
05/29/2001 | CA2171638C The semaphorin gene family |
05/29/2001 | CA2143477C Low-temperature inactive industrial baker's yeast |
05/29/2001 | CA2086250C Process for preparation of beta-lactams |
05/29/2001 | CA2064915C Tumour necrosis factor binding ligands |
05/29/2001 | CA2043762C Lipopeptide deacylase |
05/29/2001 | CA2034881C Factor x-laci hybrid protein |
05/29/2001 | CA2031286C Methods for the biological inactivation of nucleic acids |
05/25/2001 | WO2001036653A1 Method for preparing conjugated linoleic acid |
05/25/2001 | WO2001036618A2 Transgenic mammals into which a period 1 promoter that confers rhythmical expression has been introduced |
05/25/2001 | WO2001036601A1 Method for the preparation of purified hcv rna by exosome separation |
05/25/2001 | WO2001036591A1 Yunnan sl-001 strain |
05/25/2001 | WO2001036434A1 Preparation of a macrocyclic lactone |
05/25/2001 | WO2000010582A8 Probiotic, lactic acid-producing bacteria and uses thereof |
05/25/2001 | CA2390572A1 Method for preparing conjugated linoleic acid |
05/25/2001 | CA2388824A1 Preparation of a macrocyclic lactone |
05/25/2001 | CA2324496A1 New nucleotide sequences coding for the genes succ and sucd |
05/24/2001 | US20010001711 Bacterial strain, processed plant extracts, compositions containing same, processes for their preparation and their therapeutic and industrial applications |